131 related articles for article (PubMed ID: 35717957)
1. Clozapine and the risk of haematological malignancies.
Schulte PF; Cohen D; Veerman SR; Bakker B; Bogers JP
Lancet Psychiatry; 2022 Jul; 9(7):538-539. PubMed ID: 35717957
[No Abstract] [Full Text] [Related]
2. Clozapine and the risk of haematological malignancies.
de Leon J; De Las Cuevas C; Sanz EJ; Ruan CJ; Correll CU
Lancet Psychiatry; 2022 Jul; 9(7):537-538. PubMed ID: 35717956
[No Abstract] [Full Text] [Related]
3. Clozapine and the risk of haematological malignancies - Authors' reply.
Tiihonen J; Tanskanen A; Bell JS; Dawson JL; Kataja V; Taipale H
Lancet Psychiatry; 2022 Jul; 9(7):539-540. PubMed ID: 35717958
[No Abstract] [Full Text] [Related]
4. Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland.
Tiihonen J; Tanskanen A; Bell JS; Dawson JL; Kataja V; Taipale H
Lancet Psychiatry; 2022 May; 9(5):353-362. PubMed ID: 35334224
[TBL] [Abstract][Full Text] [Related]
5. Response to 'The association of clozapine and haematological malignancies needs to be replicated by other studies and more importantly by analyses of subsamples from VigiBase'.
Chrétien B; Lelong-Boulouard V; Alexandre J; Fedrizzi S; Dolladille C
Psychol Med; 2021 Jun; 51(8):1407-1408. PubMed ID: 32635951
[No Abstract] [Full Text] [Related]
6. Haematologic malignancies associated with clozapine
Chrétien B; Lelong-Boulouard V; Chantepie S; Sassier M; Bertho M; Brazo P; Humbert X; Alexandre J; Fedrizzi S; Dolladille C
Psychol Med; 2021 Jul; 51(9):1459-1466. PubMed ID: 32036793
[TBL] [Abstract][Full Text] [Related]
7. The association of clozapine and haematological malignancies needs to be replicated by other studies and more importantly by analyses of subsamples from VigiBase.
de Leon J; De Las Cuevas C; Sanz EJ; Verdoux H
Psychol Med; 2021 Jun; 51(8):1405-1406. PubMed ID: 32372739
[No Abstract] [Full Text] [Related]
8. Haematological monitoring with clozapine therapy in India.
Tharyan P
Br J Psychiatry; 1998 Jun; 172():540. PubMed ID: 9828998
[No Abstract] [Full Text] [Related]
9. Paradoxical pattern of haematological risk with clozapine.
Gillman K
Br J Psychiatry; 2000 Jul; 177():88. PubMed ID: 10945101
[No Abstract] [Full Text] [Related]
10. Haematological safety of antipsychotic drugs.
Hall RL; Smith AG; Edwards JG
Expert Opin Drug Saf; 2003 Jul; 2(4):395-9. PubMed ID: 12904095
[TBL] [Abstract][Full Text] [Related]
11. Olanzapine-induced neutropenia after clozapine-induced neutropenia.
Benedetti F; Cavallaro R; Smeraldi E
Lancet; 1999 Aug; 354(9178):567. PubMed ID: 10470706
[TBL] [Abstract][Full Text] [Related]
12. Clozapine-induced late leukopenia.
Latif Z; Malik MA; Jabbar F; Ahmed Y; McDonough C
Ir J Med Sci; 2012 Mar; 181(1):139-41. PubMed ID: 20872253
[TBL] [Abstract][Full Text] [Related]
13. Haematological toxicity of clozapine and some other drugs used in psychiatry.
Nooijen PM; Carvalho F; Flanagan RJ
Hum Psychopharmacol; 2011 Mar; 26(2):112-9. PubMed ID: 21416507
[TBL] [Abstract][Full Text] [Related]
14. Haematological side effects associated with clozapine: A retrospective study from India.
Grover S; Shouan A; Chakrabarti S; Avasthi A
Asian J Psychiatr; 2020 Feb; 48():101906. PubMed ID: 31865196
[TBL] [Abstract][Full Text] [Related]
15. A case of clozapine-induced paralytic ileus.
Rondla S; Crane S
Emerg Med J; 2007 Feb; 24(2):e12. PubMed ID: 17251601
[TBL] [Abstract][Full Text] [Related]
16. Haematological monitoring in psychiatry.
Latif Z
Ir J Med Sci; 2010 Jun; 179(2):317. PubMed ID: 19711017
[No Abstract] [Full Text] [Related]
17. Prolongation of clozapine-induced leukopenia with olanzapine treatment.
Sayin A; Cosar B
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):958-9. PubMed ID: 16631295
[TBL] [Abstract][Full Text] [Related]
18. Clozapine and blood dyscrasias different from agranulocytosis.
Barbui C; Campomori A; Bonati M
Can J Psychiatry; 1997 Nov; 42(9):981-2. PubMed ID: 9429071
[No Abstract] [Full Text] [Related]
19. A review of clozapine safety.
Fitzsimons J; Berk M; Lambert T; Bourin M; Dodd S
Expert Opin Drug Saf; 2005 Jul; 4(4):731-44. PubMed ID: 16011451
[TBL] [Abstract][Full Text] [Related]
20. [Risk minimization evolution of agranulocytosis caused by the administration of pharmaceutical products containing Clozapine in Argentina].
Bergman M; Bignone I; Bisio A; Bologna V; Sabatini A
Vertex; 2011; 22(96):94-7. PubMed ID: 21977603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
